1. Home
  2. BFC vs HRMY Comparison

BFC vs HRMY Comparison

Compare BFC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$132.21

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$27.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
HRMY
Founded
1894
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
BFC
HRMY
Price
$132.21
$27.44
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$150.00
$46.70
AVG Volume (30 Days)
75.8K
683.7K
Earning Date
04-14-2026
05-05-2026
Dividend Yield
1.51%
N/A
EPS Growth
11.23
7.97
EPS
7.23
2.71
Revenue
N/A
$868,453,000.00
Revenue This Year
$58.67
$19.75
Revenue Next Year
$2.01
$12.88
P/E Ratio
$18.31
$10.18
Revenue Growth
N/A
21.51
52 Week Low
$93.00
$25.52
52 Week High
$153.00
$40.87

Technical Indicators

Market Signals
Indicator
BFC
HRMY
Relative Strength Index (RSI) 41.48 34.69
Support Level $118.71 $25.71
Resistance Level $133.35 $28.99
Average True Range (ATR) 4.11 0.71
MACD -0.27 0.22
Stochastic Oscillator 20.89 31.70

Price Performance

Historical Comparison
BFC
HRMY

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: